Research

LIke ThisLIke ThisLIke This

Christopher  Weldon, MD, PhD

Christopher Weldon
Research Center:
Dana-Farber/Boston Children’s Cancer and Blood Disorders Center
Department:
Surgery Research
Hospital Title:
Assistant in Surgery
Academic Title:
Instructor in Surgery
Research Focus Area:
chemo-resistance pathways in solid tumors
Contact Via Email
Send an email to SendYour Name*Your Email Address*Subject*Comments*

Research Overview

Dr. Weldon's research focuses on the development of novel drug-delivery platforms. His work is conducted under the mentoring of Dr. Daniel Kohane, M.D., Ph.D, in the Department of Anesthesia.

About Christopher Weldon

Dr. Weldon was born and raised in California, and then attended the University of Notre Dame, where he received a Bachelor of Arts Degree in English and Pre-Professional Studies. After earning his undergraduate degree, he attended Tulane University Medical Schol, where he graduated in 1995. He then entered the Surgical Residency training program at Tulane Medical Center/Charity Hospital where he completed his General Surgery Residency and Surgical Critical Care Fellowship. While a resident he also received a Doctorate of Philosophy in Pharmacology from the Tulane University Graduate School. After these endeavors, he finished a Pediatric Surgery Fellowship at Boston Children's Hospital.

Publications

Publications powered by Harvard Catalyst Profiles
  1. O'Neill AF, Towbin AJ, Krailo MD, Xia C, Gao Y, McCarville MB, Meyers RL, McGahren ED, Tiao GM, Dunn SP, Langham MR, Weldon CB, Finegold MJ, Ranganathan S, Furman WL, Malogolowkin M, Rodriguez-Galindo C, Katzenstein HM. Characterization of Pulmonary Metastases in Children With Hepatoblastoma Treated on Children's Oncology Group Protocol AHEP0731 (The Treatment of Children With All Stages of Hepatoblastoma): A Report From the Children's Oncology Group. J Clin Oncol. 2017 Oct 20; 35(30):3465-3473.
  2. Madenci AL, Li GZ, Weil BR, Zurakowski D, Kang PB, Weldon CB. The role of thymectomy in the treatment of juvenile myasthenia gravis: a systematic review. Pediatr Surg Int. 2017 Jun; 33(6):683-694.
  3. Wolter NE, Adil E, Irace AL, Werger A, Perez-Atayde AR, Weldon C, Orbach DB, Rodriguez-Galindo C, Rahbar R. Malignant glomus tumors of the head and neck in children and adults: Evaluation and management. Laryngoscope. 2017 Dec; 127(12):2873-2882.
  4. Weldon CB, Madenci AL, Boikos SA, Janeway KA, George S, von Mehren M, Pappo AS, Schiffman JD, Wright J, Trent JC, Pacak K, Stratakis CA, Helman LJ, La Quaglia MP. Surgical Management of Wild-Type Gastrointestinal Stromal Tumors: A Report From the National Institutes of Health Pediatric and Wildtype GIST Clinic. J Clin Oncol. 2016 Dec 28; JCO2016686733.
  5. Mullassery D, Weldon CB. Pediatric/"Wildtype" gastrointestinal stromal tumors. Semin Pediatr Surg. 2016 Oct; 25(5):305-310.
  6. Devji TF, Madenci AL, Carpino E, Leahy IC, Samnaliev M, Dearden JL, Weil BR, Weldon CB, Cravero J. Safety and cost-effectiveness of port removal outside of the operating room among pediatric patients. J Pediatr Surg. 2016 Nov; 51(11):1891-1895.
  7. Madenci AL, Stetson A, Weldon CB, Lehmann LE. Safety of peritoneal and pleural drain placement in pediatric stem cell transplant recipients with severe veno-occlusive disease. Pediatr Transplant. 2016 Aug; 20(5):687-91.
  8. Boikos SA, Pappo AS, Killian JK, LaQuaglia MP, Weldon CB, George S, Trent JC, von Mehren M, Wright JA, Schiffman JD, Raygada M, Pacak K, Meltzer PS, Miettinen MM, Stratakis C, Janeway KA, Helman LJ. Molecular Subtypes of KIT/PDGFRA Wild-Type Gastrointestinal Stromal Tumors: A Report From the National Institutes of Health Gastrointestinal Stromal Tumor Clinic. JAMA Oncol. 2016 Jul 01; 2(7):922-8.
  9. Madenci AL, Levine BS, Laufer MR, Boyd TK, Voss SD, Zurakowski D, Frazier AL, Weldon CB. Preoperative risk stratification of children with ovarian tumors. J Pediatr Surg. 2016 Sep; 51(9):1507-12.
  10. Madenci AL, Levine BS, Laufer MR, Boyd TK, Voss SD, Frazier AL, Weldon CB. Poor adherence to staging guidelines for children with malignant ovarian tumors. J Pediatr Surg. 2016 Sep; 51(9):1513-7.
  11. Show all
  12. Vadva Z, Laufer MR, Weldon CB, Frazier AL, Vargas SO. Diagnostic Impact of Peritoneal Fluid Cytology in the Setting of Pediatric Uterine Adnexal Biopsy or Resection. Pediatr Dev Pathol. 2016 Sep/Oct; 19(5):401-408.
  13. Madenci AL, Fisher S, Diller LR, Goldsby RE, Leisenring WM, Oeffinger KC, Robison LL, Sklar CA, Stovall M, Weathers RE, Armstrong GT, Yasui Y, Weldon CB. Intestinal Obstruction in Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study. J Clin Oncol. 2015 Sep 10; 33(26):2893-900.
  14. Mazziotti MV, Weldon CB, Lopez ME, Abbas PI, Rescorla FJ, Kim ES. Analysis of submitted abstracts for the American Academy of Pediatrics, Section on Surgery, National Conference (AAP SoSU). J Pediatr Surg. 2015 Jun; 50(6):1058-61.
  15. Zalieckas J, Weldon C. Sedation and analgesia in the ICU. Semin Pediatr Surg. 2015 Feb; 24(1):37-46.
  16. Madenci AL, Lehmann LE, Weldon CB. Surgical consultation and intervention during pediatric hematopoietic stem cell transplantation. Pediatr Transplant. 2014 Dec; 18(8):875-81.
  17. Liew WK, Powell CA, Sloan SR, Shamberger RC, Weldon CB, Darras BT, Kang PB. Comparison of plasmapheresis and intravenous immunoglobulin as maintenance therapies for juvenile myasthenia gravis. JAMA Neurol. 2014 May; 71(5):575-80.
  18. Madenci AL, Stoffan AP, Rajagopal SK, Blinder JJ, Emani SM, Thiagarajan RR, Weldon CB. Factors associated with survival in patients who undergo peritoneal dialysis catheter placement following cardiac surgery. J Pediatr Surg. 2013 Jun; 48(6):1269-76.
  19. Madenci AL, Thiagarajan RR, Stoffan AP, Emani SM, Rajagopal SK, Weldon CB. Characterizing peritoneal dialysis catheter use in pediatric patients after cardiac surgery. J Thorac Cardiovasc Surg. 2013 Aug; 146(2):334-8.
  20. Frazier AL, Weldon C, Amatruda J. Fetal and neonatal germ cell tumors. Semin Fetal Neonatal Med. 2012 Aug; 17(4):222-30.
  21. Collins-Burow BM, Antoon JW, Frigo DE, Elliott S, Weldon CB, Boue SM, Beckman BS, Curiel TJ, Alam J, McLachlan JA, Burow ME. Antiestrogenic activity of flavonoid phytochemicals mediated via the c-Jun N-terminal protein kinase pathway. Cell-type specific regulation of estrogen receptor alpha. J Steroid Biochem Mol Biol. 2012 Oct; 132(1-2):186-93.
  22. Weldon CB, Tsui JH, Shankarappa SA, Nguyen VT, Ma M, Anderson DG, Kohane DS. Electrospun drug-eluting sutures for local anesthesia. J Control Release. 2012 Aug 10; 161(3):903-9.
  23. Janeway KA, Weldon CB. Pediatric gastrointestinal stromal tumor. Semin Pediatr Surg. 2012 Feb; 21(1):31-43.
  24. Klein JD, Turner CG, Gray FL, Yu DC, Kozakewich HP, Perez-Atayde AR, Voss SD, Zurakowski D, Shamberger RC, Weldon CB. Adrenal cortical tumors in children: factors associated with poor outcome. J Pediatr Surg. 2011 Jun; 46(6):1201-7.
  25. Weldon CB, Trosman JR, Dupuy D, Alvarez R, Marcus EA, Schink JC, Murphy AM. Facilitators of quality breast cancer screening and diagnosis in an urban environment. J Clin Oncol. 2011 May 20; 29(15_suppl):e16584.
  26. Doll KM, Weldon CB, Trosman JR, Wetzel HH, Fallen TJ, Gradishar WJ, Schink JC. BRCA+ test result impact and timing on surgical treatment decisions for patients with breast cancer. J Clin Oncol. 2011 May 20; 29(15_suppl):626.
  27. Tsongalis GJ, Weldon CB, Trosman JR, Gradishar WJ, Schink JC. Barriers to implementing primary HER2 FISH testing. J Clin Oncol. 2011 May 20; 29(15_suppl):e16642.
  28. Trosman JR, Weldon CB, Benson AB, Gradishar WJ, Schink JC. Oncology Medical Home to address challenges in breast cancer care delivery. J Clin Oncol. 2011 May 20; 29(15_suppl):e16641.
  29. Schink JC, Doll KM, Weldon CB, Trosman JR, Wetzel HH, Fallen TJ, Gradishar WJ. Prophylactic oophorectomy for patients with breast cancer with BRCA results. J Clin Oncol. 2011 May 20; 29(15_suppl):1533.
  30. Lee EY, Tracy DA, Mahmood SA, Weldon CB, Zurakowski D, Boiselle PM. Preoperative MDCT evaluation of congenital lung anomalies in children: comparison of axial, multiplanar, and 3D images. AJR Am J Roentgenol. 2011 May; 196(5):1040-6.
  31. Weldon C, Tian B, Kohane DS. Nanotechnology for surgeons. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2011 May-Jun; 3(3):223-8.
  32. Mariño-Enríquez A, Ou WB, Weldon CB, Fletcher JA, Pérez-Atayde AR. ALK rearrangement in sickle cell trait-associated renal medullary carcinoma. Genes Chromosomes Cancer. 2011 Mar; 50(3):146-53.
  33. Bratton MR, Duong BN, Elliott S, Weldon CB, Beckman BS, McLachlan JA, Burow ME. Regulation of ERalpha-mediated transcription of Bcl-2 by PI3K-AKT crosstalk: implications for breast cancer cell survival. Int J Oncol. 2010 Sep; 37(3):541-50.
  34. Yu DC, Grabowski MJ, Kozakewich HP, Perez-Atayde AR, Voss SD, Shamberger RC, Weldon CB. Primary lung tumors in children and adolescents: a 90-year experience. J Pediatr Surg. 2010 Jun; 45(6):1090-5.
  35. Rosen H, Webb ML, DiVasta AD, Greene AK, Weldon CB, Kozakewich H, Perez-Atayde AR, Labow BI. Adolescent gynecomastia: not only an obesity issue. Ann Plast Surg. 2010 May; 64(5):688-90.
  36. Yu DC, Kozakewich HP, Perez-Atayde AR, Shamberger RC, Weldon CB. Childhood pancreatic tumors: a single institution experience. J Pediatr Surg. 2009 Dec; 44(12):2267-72.
  37. Yu DC, Voss SD, Javid PJ, Jennings RW, Weldon CB. In utero diagnosis of congenital pyloric atresia in a single twin using MRI and ultrasound. J Pediatr Surg. 2009 Nov; 44(11):e21-4.
  38. Yu DC, Grabowski MJ, Feins NR, Weldon CB. H-type rectovaginal fistula in a patient with bilateral single ectopic ureters. J Pediatr Surg. 2009 Oct; 44(10):e27-30.
  39. Misra MV, Smithers CJ, Krawczuk LE, Jenkins RL, Linden BC, Weldon CB, Kim HB. Reduced size liver transplantation from a donor supported by a Berlin Heart. Am J Transplant. 2009 Nov; 9(11):2641-3.
  40. Fitzgibbons SC, Ching Y, Yu D, Carpenter J, Kenny M, Weldon C, Lillehei C, Valim C, Horbar JD, Jaksic T. Mortality of necrotizing enterocolitis expressed by birth weight categories. J Pediatr Surg. 2009 Jun; 44(6):1072-5; discussion 1075-6.
  41. Yu DC, Thiagarajan RR, Laussen PC, Laussen JP, Jaksic T, Weldon CB. Outcomes after the Ladd procedure in patients with heterotaxy syndrome, congenital heart disease, and intestinal malrotation. J Pediatr Surg. 2009 Jun; 44(6):1089-95; discussion 1095.
  42. Yu DC, Javid PJ, Chikwava KR, Kozakewich HP, Debiec-Rychter M, Lillehei CW, Weldon CB. Mesenteric lipoblastoma presenting as a segmental volvulus. J Pediatr Surg. 2009 Feb; 44(2):e25-8.
  43. Yu DC, Linden BC, Anderson ME, Weldon CB. Use of a distal arteriovenous fistula in a complex vascular reconstruction after resection of an osteosarcoma in a high-risk child. J Pediatr Surg. 2009 Feb; 44(2):459-63.
  44. Zhou C, Nitschke AM, Xiong W, Zhang Q, Tang Y, Bloch M, Elliott S, Zhu Y, Bazzone L, Yu D, Weldon CB, Schiff R, McLachlan JA, Beckman BS, Wiese TE, Nephew KP, Shan B, Burow ME, Wang G. Proteomic analysis of tumor necrosis factor-alpha resistant human breast cancer cells reveals a MEK5/Erk5-mediated epithelial-mesenchymal transition phenotype. Breast Cancer Res. 2008; 10(6):R105.
  45. Gutweiler JR, Yu DC, Kim HB, Kozakewich HP, Marcus KJ, Shamberger RC, Weldon CB. Hepatoblastoma presenting with focal nodular hyperplasia after treatment of neuroblastoma. J Pediatr Surg. 2008 Dec; 43(12):2297-300.
  46. Gutweiler JR, Labelle J, Suh MY, Misra MV, Ahmed M, Lee EY, Vargas SO, Kim HB, Weldon CB. A familial case of pleuropulmonary blastoma. Eur J Pediatr Surg. 2008 Jun; 18(3):192-4.
  47. Weldon CB, Shamberger RC. Pediatric pulmonary tumors: primary and metastatic. Semin Pediatr Surg. 2008 Feb; 17(1):17-29.
  48. Weldon CB, Shamberger RC. Pediatric Pulmonary Tumors. Seminars in Pediatric Surgery. 2008; in press..
  49. Hendren WH, Weldon CB. Congenital Esophageal Disorders. Operative Thoracic Surgery. 2008; in press/submitted..
  50. Gutweiler JR, LaBelle J, Suh MY, Misra MV, Ahmed M, Lee EY, Vargas SO, Kim HB, Weldon CB. A Familial Case of Pleuropulmonary Blastoma. European Journal of Pediatric Surgery. 2008; in press..
  51. Anderson ME, Gebhardt MC, Weldon CB, Shamberger RC. Surgical Aspects of Pediatric Oncology. Nathan and Oski’s Pediatric Hematology and Oncology. 2008; in press/submitted..
  52. Frigo DE, Basu A, Nierth-Simpson EN, Weldon CB, Dugan CM, Elliott S, Collins-Burow BM, Salvo VA, Zhu Y, Melnik LI, Lopez GN, Kushner PJ, Curiel TJ, Rowan BG, McLachlan JA, Burow ME. p38 mitogen-activated protein kinase stimulates estrogen-mediated transcription and proliferation through the phosphorylation and potentiation of the p160 coactivator glucocorticoid receptor-interacting protein 1. Mol Endocrinol. 2006 May; 20(5):971-83.
  53. Frigo DE, Basu A, Nierth-Simpson EN, Weldon CB, Dugan CM, Elliot S, Collins-Burow BM, Salvo VA, Zhu Y, melnik LI, Lopez GN, Kushner PJ, Curiel TJ, Rowan BG, McLachlan JA, Burow, ME. P38 mitogen-activated protein kinase stimulates estrogen-mediated transcription and proliferation through the phosphorylation and potentiation of the p160 coactivator glucocorticoid receptor-interacting protein1. Molecular Endocrinology,. 2006; 20(5):971-983..
  54. Weldon CB, McKee A, Collins-Burow BM, Melnik LI, Scandurro AB, McLachlan JA, Burow ME, Beckman BS. PKC-mediated survival signaling in breast carcinoma cells: a role for MEK1-AP1 signaling. Int J Oncol. 2005 Mar; 26(3):763-8.
  55. Nichols RL, Choe EU, Weldon CB. Mechanical and antibacterial bowel preparation in colon and rectal surgery. Chemotherapy. 2005; 51 Suppl 1:115-21.
  56. Weldon CB, Elliott S, Zhu Y, Clayton JL, Curiel TJ, Jaffe BM, Burow ME. Regulation of estrogen-mediated cell survival and proliferation by p160 coactivators. Surgery. 2004 Aug; 136(2):346-54.
  57. Weldon CB, Parker AP, Patten D, Elliott S, Tang Y, Frigo DE, Dugan CM, Coakley EL, Butler NN, Clayton JL, Alam J, Curiel TJ, Beckman BS, Jaffe BM, Burow ME. Sensitization of apoptotically-resistant breast carcinoma cells to TNF and TRAIL by inhibition of p38 mitogen-activated protein kinase signaling. Int J Oncol. 2004 Jun; 24(6):1473-80.
  58. Madan AK, Weldon CB, Long WP, Johnson D, Raafat A. Solid and papillary epithelial neoplasm of the pancreas. J Surg Oncol. 2004 Mar 15; 85(4):193-8.
  59. Simstein R, Burow M, Parker A, Weldon C, Beckman B. Apoptosis, chemoresistance, and breast cancer: insights from the MCF-7 cell model system. Exp Biol Med (Maywood). 2003 Oct; 228(9):995-1003.
  60. Hopson LR, Hirsh E, Delgado J, Domeier RM, Krohmer J, McSwain NE, Weldon C, Friel M, Hoyt DB. Guidelines for withholding or termination of resuscitation in prehospital traumatic cardiopulmonary arrest. J Am Coll Surg. 2003 Mar; 196(3):475-81.
  61. Weldon CB, Parker AP, Patten D, Elliot S, Tang Y, Frigo DE, Butler NN, Clayton JL, Alam J, Curiel TJ, Beckman BS, Jaffe BM, Burow ME. Sensitization of Apoptotically Resistant Breast Carcinoma Cells to TNF and TRAIL by Inhibition of P38 Mitogen-Activated Protein Kinase Signaling. Proceedings of the Society of Surgical Oncology. 2003.
  62. Hopson lr, Hirch E, Delgado J, Domeier RM, Krohmer J, McSwain NE Jr, Weldon C, Friel M, Hoyt DB; National Association of EMS Physicians Standards and Clinical Practice Committee, American College of Surgeons Committee on Trauma. Guidelines for withholding or termination of resuscitation in prehospital cardiopulmonary arrest. Journal of American College of Surgeons,. 2003; 196(3):475-81..
  63. Weldon CB, Jaffe BM, Kahn MJ. Therapy-induced leukemias and myelodysplastic syndromes after breast cancer treatment: an underemphasized clinical problem. Ann Surg Oncol. 2002 Oct; 9(8):738-44.
  64. Weldon CB, Scandurro AB, Rolfe KW, Clayton JL, Elliott S, Butler NN, Melnik LI, Alam J, McLachlan JA, Jaffe BM, Beckman BS, Burow ME. Identification of mitogen-activated protein kinase kinase as a chemoresistant pathway in MCF-7 cells by using gene expression microarray. Surgery. 2002 Aug; 132(2):293-301.
  65. Weldon CB, Silberfein E, Chehardy PL, McSwain NE. ATLS training: a novel approach. Bull Am Coll Surg. 2002 Apr; 87(4):15-9.
  66. Weldon CB, Siberfein E, Chehardy PL, McSwain NE. Advanced Trauma Life Support Training: A novel approach. Bulletin of the American College of Surgeons,. 2002; 87(4):15-19..
  67. Weldon CB, Jaffe BM, Kahn ML. Therapy-induced leukemias and myelodysplastic syndromes following breast cancer treatment. Ann Surgical Oncology. 2002; 9(8):738-744.
  68. Weldon CB, Scandurro AB, Rolfe KW, Clayton JL, Butler NN, Melnik LI, Alam J, McLachlan JA, Jaffe BM, Beckman BS, Burow ME. Identification of mitogen-activated protein kinase kinase 5 (mek5) as a chemoresistance pathway in MCF-7 cells using gene expression microarray. Basic Science Plenary Session, Proceedings of the Society of University Surgeons. 2002.
  69. Weldon CB, Scandurro AB, Rolfe KW, Clayton JL, Elliot S, Butler NN, Melnik LI, Alam J, McLachlan JA, Jaffe BM, Beckman BS, Burow ME . Identification of mitogen-activated protein kinase kinase 5 (MEK5) as a chemoresistance pathway in MCF-7 cells using gene expression microarray. Surgery,. 2002; 132(2):292-301..
  70. Burow ME, Weldon CB, Tang Y, McLachlan JA, Beckman BS. Oestrogen-mediated suppression of tumour necrosis factor alpha-induced apoptosis in MCF-7 cells: subversion of Bcl-2 by anti-oestrogens. J Steroid Biochem Mol Biol. 2001 Nov; 78(5):409-18.
  71. Weldon CB, Burow ME, Rolfe KW, Clayton JL, Jaffe BM, Beckman BS. NF-kappa B-mediated chemoresistance in breast cancer cells. Surgery. 2001 Aug; 130(2):143-50.
  72. Madan AK, Long AE, Weldon CB, Jaffe BM. Esophageal carcinosarcoma. J Gastrointest Surg. 2001 Jul-Aug; 5(4):414-7.
  73. Scandurro AB, Weldon CW, Figueroa YG, Alam J, Beckman BS. Gene microarray analysis reveals a novel hypoxia signal transduction pathway in human hepatocellular carcinoma cells. Int J Oncol. 2001 Jul; 19(1):129-35.
  74. Weldon CB*, Burow ME*, Yan T, McLachlan JA, Beckman BS. *co-first authorship. Oestrogen-mediated suppression of TNF-induced apoptosis in MCF-7 cells:subversion of Bcl-2 by antioestrogens. Journal of Ster Biochemistry Mol Biol.,. 2001; 78(5):409-418..
  75. Weldon CB, Burow ME, Jaffe BM, Beckman BS. NF-kappa â-mediated chemoresistance in breast cancer cells. Proceedings of the Society of University Surgeons. 2001.
  76. Weldon CB, Friel MT, Clayton JL, McSwain NE. Pre-hospital DNR Protocol: An idea whose time has arrived. Winner, Clinical Trauma Paper Competition. Louisiana State Committee on Trauma. Resident Paper Competition. 2001.
  77. Weldon CB. Identification and analysis of molecular mechanisms of chemoresistance in human breast carcinoma cells. 2001.
  78. Weldon CB, Burow ME, Beckman BS, Jaffe BM. Identification of chemoresisstance targets in MCF-7 cells using gene microarray. Proceedings of the Society of Surgical Oncology. 2001.
  79. Madan AK, Long AE, Weldon CB, Jaffe BM. Esophageal carcinosarcoma. Journal of Gastrointestinal Surgery. 2001; 5(4):414-417..
  80. Burow ME, Weldon CB, Chiang TC, Tang Y, Collins-Burow BM, Rolfe K, Li S, McLachlan JA, Beckman BS. Differences in protein kinase C and estrogen receptor alpha, beta expression and signaling correlate with apoptotic sensitivity of MCF-7 breast cancer cell variants. Int J Oncol. 2000 Jun; 16(6):1179-87.
  81. Burow ME, Weldon CB, Melnik LI, Duong BN, Collins-Burow BM, Beckman BS, McLachlan JA. PI3-K/AKT regulation of NF-kappaB signaling events in suppression of TNF-induced apoptosis. Biochem Biophys Res Commun. 2000 May 10; 271(2):342-5.
  82. Burow ME, Weldon CB, Collins-Burow BM, Ramsey N, McKee A, Klippel A, McLachlan JA, Clejan S, Beckman BS. Cross-talk between phosphatidylinositol 3-kinase and sphingomyelinase pathways as a mechanism for cell survival/death decisions. J Biol Chem. 2000 Mar 31; 275(13):9628-35.
  83. Beckman BS, Weldon CB, Clejan S, Rolfe KW, Hammond TG, Burow ME . Modulation of apoptotic pathways for therapeutic advantage: MCF-7 cells as a model system. Proceedings of the 5th Annual Multidisciplinary Symposium on Breast Disease. 2000.
  84. Weldon CB, Burow ME, Clejan S, Rolfe K, Hammond TG, Beckman BS. Modulation of apoptotic pathways for therapeutic advantage in breast cancer. Proceedings of the American Society for Pharmacology and Experimental Therapeutics. 2000; 14(A1516).
  85. Weldon CB*, Burrow ME*, Chiang, TC, Tang Y, Collins-Burow BM, Rolfe K, Li S, McLachlan JA, Beckman BS. *co-first authorship. Differences in protein kinase C and estrogen receptor á, â expression and signaling correlate with apoptotic sensitivity of MCF-7 breast cancer cell variants. International Journal of Oncology,. 2000; 16(6):1179-1187..
  86. Weldon CB*, Burow ME*, Melnik L, Duong B, Collins-Burow BM, Klippel A, Beckman BS, McLachlan JA. *co-first authorship. Phosphatidylinositol 3-kinase/Akt mediated regulation of NF-êB signaling events as a mechanism for suppression of TNF-induced apoptosis. Biochemistry Biophysiology Res Commun,. 2000; 271(2):342-345..
  87. Weldon CB, Burow ME, Beckman BS. Characterization of chemoresistance of MCF-7/ADR breast cancer cells. Proceedings of the Society of University Surgeons, Residents’ Conference. 2000.
  88. Rolfe K, Weldon CB, Burow ME, Beckman BS. MCF-7/ADR breast cancer cell chemonresistance. Proceedings of the American Association of Cancer Research. 2000.
  89. Burow ME, Weldon CB, Tang Y, Navar GL, Krajewski S, Reed JC, Hammond TG, Clejan S, Beckman BS. Differences in susceptibility to tumor necrosis factor alpha-induced apoptosis among MCF-7 breast cancer cell variants. Cancer Res. 1998 Nov 01; 58(21):4940-6.
  90. Burow, ME, Weldon CB, McKee A, Clejan S, Beckman BS. Phorbol ester and insulin-like growth factor-I suppression of TNF-á-induced apoptosis through a phosphatidylinositol-3-kinase mediated inhibition of ceramide formation and caspase activation. Proceedings of the American Association for Cancer Research special conference on Molecular Mechanisms of Apoptosis Regulation. 1998.
  91. Weldon C, Jones B, Daroca P, Beech D. Breast Leiomyoma. Journal of Louisiana State Medical Society. 1998; 150(8):367-370..
  92. Burrow M, Weldon C, Tang Y, Navar G, Krajewski S, Reed J, Hammond T, Clejan S, Beckman B. Differences in susceptibility to tumor necrosis factor á-induced apoptosis among MCF-7 breast cancer cell variants. Cancer Research,. 1998; 58:4940-4946..
  93. Weldon C, Burow M, Tang Y, Navar G, Krajewski S, Reed J, Hammond T, Clejan S, Beckman B . MCF-7 breast cancer cell variants display differences in tumor necrosis factor á-included apoptosis. Proceedings of the Society of University Surgeons, Residents’ Conference. 1998.
  94. Burrow M, Weldon C, Collins-Burow BM, Ramsey N, McKee A, Klippel A, McLachlan JA, Clejan S, Bechman BS. Cross-talk between phosphatidylinositol-3 kinase and sphingomyelinase pathways as a mechanism for cell survival/death decisions. Journal of Biology and Chemistry,. 1998; 275(13):9628-9635..
  95. Burow ME, Weldon CB, Tang Y, Navar GL, Krajewski S, Reed JC, Hammond TG, Clejan S and Beckman BS . Differences in susceptibility to tumor necrosis factor- á-induced apoptosis among MCF-7 breast cancer cell variants. Proceedings of the American Association for Cancer Research. 1998.
  96. Seltzer B, Cola MG, Gutierrez C, Massee M, Weldon C, Cusick CG. Overlapping and nonoverlapping cortical projections to cortex of the superior temporal sulcus in the rhesus monkey: double anterograde tracer studies. J Comp Neurol. 1996 Jun 24; 370(2):173-90.
  97. Seltzer B, Cola M, Weldon C, Massee M, Cusick C. Parvalbumin staining delineates superior temporal polymodal cortex in Macaca mulatta. Proceedings of the Society of Neuroscience. 1993; (19):972.
  98. Seltzer B, Cola M, Massee M, Weldon C, Cusick C . Organization of cortical projections to the superior temporal polymodal cortex of the rhesus: double anterograde labeling studies. Proceedings of the Society of Neuroscience. 1992; (18):295.
  99. Rousou J, Levitsky S, Gonzalez-Lavin L, Cosgrove D, Magilligan D, Weldon C, Hiebert C, Hess P, Joyce L, Bergsland J, et al. Randomized clinical trial of fibrin sealant in patients undergoing resternotomy or reoperation after cardiac operations. A multicenter study. J Thorac Cardiovasc Surg. 1989 Feb; 97(2):194-203.
  100. Laschinger JC, Vannier MW, Gutierrez F, Gronemeyer S, Weldon CS, Spray TL, Cox JL. Preoperative three-dimensional reconstruction of the heart and great vessels in patients with congenital heart disease. Technique and initial results. J Thorac Cardiovasc Surg. 1988 Sep; 96(3):464-73.
  101. Klint R, Weldon C, Hartmann A, Schad N, Hernandez A, Goldring D. Mexed-type total anomalous pulmonary venous drainage. Report of a successful surgical correction and review of the literature. J Thorac Cardiovasc Surg. 1972 Jan; 63(1):164-70.
LIke ThisLIke ThisLIke This

RELATED RESEARCH CENTER

Dana-Farber/Boston Children’s Cancer and Blood Disorders Center

Dana-Farber/Boston Children's Cancer and Blood Disorders Center is one of the top research centers in the world for pediatric cancers and blood diseases. It brings together laboratory scientists and clinical researchers from Dana-Farber Cancer Institute and Boston Children’s Hospital in a single program. We investigate pediatric cancers and non-malignant blood disorders from every angle—from examining cells under the microscope to tracking the effectiveness of current drug regimens using the most advanced molecular methods—so that we can create better treatments for children seen here and around the world.

Learn more
Close